You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

trastuzumab

Showing 26 - 50 of 525
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Esophageal Cancer, Esophageal Adenocarcinoma Trial in Amsterdam (Trastuzumab, Pertuzumab, Paclitaxel)

Recruiting
  • Esophageal Cancer
  • Esophageal Adenocarcinoma
  • Trastuzumab
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center
Jun 18, 2022

Breast Cancer Trial (Tucatinib, Eribulin, Trastuzumab)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jul 12, 2022

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +19 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 11, 2022

HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer Trial in Germany, Spain,

Recruiting
  • HER2-positive Breast Cancer
  • +4 more
  • Essen, Germany
  • +5 more
Nov 15, 2022

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting
  • Oncology
  • Infusion Reaction
  • (no location specified)
Sep 8, 2023

Adenocarcinoma of the Rectum, Locally Advanced Rectal Adenocarcinoma, Rectal Adenocarcinoma Trial in United States (Trastuzumab,

Recruiting
  • Adenocarcinoma of the Rectum
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 3, 2023

HER2-positive Advanced Breast Cancer Trial (DP303c, Trastuzumab, Vinorelbine Tartrate)

Not yet recruiting
  • HER2-positive Advanced Breast Cancer
  • (no location specified)
Jun 4, 2023

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Gastric Cancer Trial in Shanghai (HLX22, Placebo, Trastuzumab)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai East Hospital
Apr 24, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer Trial (KN026, HB1801, Pertuzumab)

Not yet recruiting
  • First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
  • (no location specified)
Apr 20, 2023

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

HER2 Positive Breast Cancer Trial in Ireland (Copanlisib, Trastuzumab)

Completed
  • HER2 Positive Breast Cancer
  • Cork, Ireland
  • +4 more
Jul 25, 2022

Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Breast Cancer
  • Cardiac Toxicity
  • trastuzumab
  • +11 more
  • Rochester, Minnesota
    Mayo Clinic Cancer Research Consortium
Jul 12, 2022

Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab
  • +6 more
  • Boston, Massachusetts
  • +2 more
May 2, 2022

Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in Copenhagen, Odense

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Trastuzumab
  • Copenhagen, Region H, Denmark
  • +1 more
Aug 10, 2022

HER2-positive Breast Cancer Trial in Philadelphia (Atezolizumab, Paclitaxel, Trastuzumab)

Suspended
  • HER2-positive Breast Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 5, 2022

Breast Tumors, Malignant Tumor of Breast Trial in Dallas (Trastuzumab, Ibrutinib 560 mg, Ibrutinib 840 mg)

Recruiting
  • Breast Neoplasms
  • Malignant Neoplasm of Breast
  • Trastuzumab
  • +3 more
  • Dallas, Texas
    10 sites incl TX, WA, VA, and NV
May 16, 2022

Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

Recruiting
  • Metastatic Breast Cancer
  • HER2 Positive Breast Carcinoma
  • Birmingham, Alabama
  • +6 more
Dec 13, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Carcinoma Breast Stage I, HER2 Positive Breast Cancer Trial in Mumbai (Trastuzumab, Placebo)

Recruiting
  • Carcinoma Breast Stage I
  • HER2 Positive Breast Cancer
  • Trastuzumab
  • Placebo
  • Mumbai, India
    Tata Memorial Centre
Apr 26, 2022